THE ITEM 9 LABS CORP. ADVANTAGE
A vertically-integrated solution
that our investors participate in.
Download Your Complimentary Special Report, "The Future of Cannabis Is Here: Franchising" in Minutes!
Recently Featured In
Item 9 Labs Corp.
This Unique Company is the First U.S. National Dispensary Franchisor
The U.S. legal cannabis market is well-positioned to help keen, local entrepreneurs thrive in the $25 billion industry. Leading the charge, Item 9 Labs Corp. (OTCQX: INLB) is offering one of the most accessible routes to success.
This Agile and Unique Company Is the First U.S. National Cannabis Franchise
The rising legalization and growing consumption of cannabis for medicinal purposes are expected to propel market growth and create demand for thousands of new legal cannabis dispensaries.
Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products. Under its Item 9 Labs product brand, the Company produces cannabis products across five core categories, including several active cannabis strains, cannabis vape products, premium concentrates and Orion vape technology. The Company’s Unity Rd. franchise brand is opening the door for keen entrepreneurs to enter the complex, but lucrative cannabis industry with a legally compliant, best-in-class cannabis dispensary franchise that empowers entrepreneurs to confidently and compliantly open their dispensary doors each day.
Item 9 Labs Corp. is offering accredited and unaccredited investors shares in the company by direct purchase for as little as a $560.00 investment. Investments from IRAs are allowed.
The Item 9 Labs Corp. has an impressive growth story:
How to Invest Immediately
Item 9 Labs Corp. has launched a global streamlined public offering. Now, anyone can become a shareholder in Item 9 Labs Corp.
Motivated by quality, driven with community.
Item 9 Labs Corp.
Reasons to Invest
Item 9 Labs has 30-plus podium awards and is available in leading Arizona dispensaries (LeafLink, 2022)
Unity Rd. is the first national cannabis dispensary franchise in the U.S., with more than 20 partners developing the brand across 10-plus states.
Unity Rd. is the first plant-touching cannabis concept to become a member of the International Franchise Association ("IFA").
Item 9 Labs currently has 20,000 square feet of cultivation and production operations.
Motivated by quality, driven with community.
invest in cannabis entrepreneurship
The Problem with Cannabis Expansion.
The complexities of operating a cannabis business make it difficult for small, independent dispensaries to understand and stay on top of all the varying regulations and everyday challenges of managing and operating a compliant and successful dispensary.
In short, here is why we believe in keeping cannabis local:
how to keep big-canna away?
Keeping Cannabis Local Is the Solution.
Unity Rd. shops are rolling out in new states and communities around the country, and keeping dispensary ownership in the hands of local entrepreneurs.
The franchise opportunity provides a solution for industry newcomers and small, locally owned and operated dispensaries to compliantly thrive, thanks to the robust backing and support of a national franchise.
Unity Rd. offers direct access to the buying power, resources and supportive network normally reserved for multi-unit cannabis operators – empowering local, independent operators to confidently open their doors each day. We believe cannabis entrepreneurship can be a life-changing opportunity for families that can create wealth for generations to come.
You are investing in an organization that’s building a national community of local cannabis entrepreneurs, changing lives for their families and surrounding communities by keeping the wealth cannabis offers in their neighborhoods.
we grow together
From cultivation to dispensaries,
we have local cannabis covered.
Our Team's Collective Achievements
300-Plus Franchise Units Sold in More than 15 Countries
45+ Cannabis & Franchise Industry Awards
17 States We Have Won Cannabis Licenses
An Experienced Team With Extensive Cannabis and Franchise Industry Expertise
“We had been looking at the cannabis space for a few years, trying to determine our best entrance that would mitigate the high risk. We knew that by partnering with a solid franchisor we wouldn’t have to go through the School of Hard Knocks and dug into cannabis franchises.
We found a few that were just selling a business plan, no long-term support, and then discovered Unity Rd. The team has a depth of history on both the retail and cultivation side with awards to back them up. We felt most comfortable with Unity Rd. versus other routes into this nascent industry.”
- Bruce and Nate Wetzel
Unity Rd. Franchise Partners father-and-son-team
A Growing Opportunity
Now Is the Right Time To Invest in the Budding Cannabis Industry.
Legal sales of cannabis in the U.S. grew 40 percent in 2021 to $25 billion, according to research from BofA Securities. The total U.S. economic impact from cannabis sales is expected to reach $160 billion in 2025.*
Legal sales of cannabis in the U.S. in 2021.
Expected total cannabis economic impact in 2025*
frequently asked questions
Questions / Answers
Don’t see your question answered below? Reach out to us at firstname.lastname@example.org
You can easily invest in our offering online using our secure investment page.
- Navigate to https://keepcannabislocal.com
- Click the “Invest Now” button
- Complete the investor registration forms
- Read the Subscription Agreement
- Type your full legal name to sign the Subscription Agreement
- Click “Make Investment”
Welcome to the Item 9 Labs Corp. investor community!
The price per share is $1.12 USD.
The minimum investment amount is $560.oo USD or 500 shares.
The maximum amount that you can invest as a unaccredited investor is 10% of the greater of your income or net worth. There is no limit for accredited investors.
An accredited investor is an individual who makes over $200,000 per year in income ($300,000 if combined with a spouse) or who has a net worth of $1 million or more, excluding their primary residence.
A unaccredited investor is anyone who does not meet at least one of the income or net worth requirements for being considered an accredited investor.
We accept payments using a U.S. bank account (ACH), wire, or IRA.
Our offering is open to both U.S. citizens as well as international investors.
Please note that the regulations of your country may restrict you from investing via Reg A+ offerings. As an investor, you must check the regulations that apply to you, in your country.
Direct SEC Link
Investor Presentation: Download PDF
You can also email us at email@example.com for more information.
You will be able to invest in this same offering until we close this funding round. We may or may not have an additional offering at some point in the future.
As an investor, you will be provided access to an investor-only website where you will be able to view your shares, investor updates, and other related documents and materials.
We aim to make an investment in Item 9 Labs Corp. both a great investment opportunity and also a great journey in which our investors can learn about our company, our brands and development. Therefore, we aim to have regular updates on our progress and activities. At a minimum, we will provide quarterly updates but we aim to have much more regular updates, (one to many per month) in the form of webinars, video updates, and email updates.
We are offering a maximum of 28,000,000 Common Shares.
Our offering will terminate on the first to occur of:
- the sale of all 28,000,000 shares offered hereby,
- February 3, 2023“(12 months after SEC Qualification Date”
- when our Board of Directors elects to terminate the offering.
“The SEC has qualified this offering” means the SEC has permitted Item 9 Labs Corp. to offer for sale the securities (also referred to as shares, stock or common stock) described in the offering circular to the general public. The SEC is not judging the merits, accuracy, or completeness of the offering and information in the offering circular. Rather, the SEC is merely ensuring Item 9 Labs Corp. has met federal legal disclosure and regulatory requirements necessary to make these shares available to you.
A subscription agreement is a legal contract between you and Item 9 Labs Corp. to purchase shares issued by the company and is required for each investment you make.
Each investment is a one-time event and no recurring payments will be withdrawn from you for that investment.
ACH transactions can take 1-2 business days to process. Once funds are received, it can take up to two weeks to process your investment completely.
Once your investment has been fully processed and confirmed, you will receive an Investment Confirmation email with your Signed Subscription Agreement and Ceremonial Certificate. You are officially an investor in Item 9 Labs Corp. only when you receive this email.
If a couple of weeks pass by and you do not receive an Investor Confirmation email with your Signed Subscription Agreement and Ceremonial Certificate, please email us at firstname.lastname@example.org. We may still require additional information from you in order to process your investment fully. We recommend you check your spam folder first for any email communications.
In some instances, we may reach out to you requesting additional information in order to finish processing your investment, which may increase the overall amount of time it takes to process your investment completely.
We will update you on, at least, a quarterly basis. You will be able to log into the investor only website to see all our updates.
Management of the company has wide latitude and discretion in the use of proceeds from this offering, including but not limited to manufacturing, marketing, business development expenses, and providing liquidity to early shareholders. Please read the ‘Use of Proceeds to the Company’ section in our offering curricular for more details on our plans for the future.
For any questions about our offering, please email us at email@example.com
or call: 520-636-6545
When we first looked into raising capital via crowdfunding, we strongly considered signing with a platform but ultimately decided to host our own raise ourselves to reduce fees and leverage our expertise in digital marketing and advertising for a more successful raise opportunity.